Histological variants of urothelial carcinoma predict no response to neoadjuvant chemotherapy (2022)
Fonte: Clinical genitourinary cancer. Unidade: FM
Assuntos: QUIMIOTERAPIA ADJUVANTE, NEOPLASIAS DA BEXIGA, NEOPLASIAS UROGENITAIS
ABNT
LEITE, Katia Ramos Moreira et al. Histological variants of urothelial carcinoma predict no response to neoadjuvant chemotherapy. Clinical genitourinary cancer, v. 20, n. 1, p. E1-E6, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clgc.2021.07.011. Acesso em: 10 set. 2024.APA
Leite, K. R. M., Borges, L. L., Ribeiro Filho, L., Chade, D., Coelho, R. F., Cordeiro, M., et al. (2022). Histological variants of urothelial carcinoma predict no response to neoadjuvant chemotherapy. Clinical genitourinary cancer, 20( 1), E1-E6. doi:10.1016/j.clgc.2021.07.011NLM
Leite KRM, Borges LL, Ribeiro Filho L, Chade D, Coelho RF, Cordeiro M, Srougi M, Nahas WC. Histological variants of urothelial carcinoma predict no response to neoadjuvant chemotherapy [Internet]. Clinical genitourinary cancer. 2022 ; 20( 1): E1-E6.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/j.clgc.2021.07.011Vancouver
Leite KRM, Borges LL, Ribeiro Filho L, Chade D, Coelho RF, Cordeiro M, Srougi M, Nahas WC. Histological variants of urothelial carcinoma predict no response to neoadjuvant chemotherapy [Internet]. Clinical genitourinary cancer. 2022 ; 20( 1): E1-E6.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/j.clgc.2021.07.011